Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 263 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| DermTech Inc | DMTK | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.3154 | 04:30:56 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.3154 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 2 | 263 | - | 0.30 - 3.8984 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 04:00:16 | formt | 254 | US$ 0.3154 | USD |
DermTech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 11.03M | - | - | - | -0.11 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
DermTech News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DMTK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3809 | 0.3809 | 0.30 | 0.329314 | 428,689 | -0.0655 | -17.20% |
| 1 Month | 0.61 | 0.675 | 0.30 | 0.416009 | 1,298,159 | -0.2946 | -48.30% |
| 3 Months | 0.675 | 0.7372 | 0.30 | 0.4716132 | 556,631 | -0.3596 | -53.27% |
| 6 Months | 1.48 | 1.99 | 0.30 | 0.928989 | 545,700 | -1.16 | -78.69% |
| 1 Year | 2.48 | 3.8984 | 0.30 | 1.39 | 417,171 | -2.16 | -87.28% |
| 3 Years | 39.00 | 48.32 | 0.30 | 10.64 | 572,478 | -38.68 | -99.19% |
| 5 Years | 5.48 | 84.49 | 0.30 | 20.42 | 521,739 | -5.16 | -94.24% |
DermTech Description
| DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services. |
